[Daily practice using the guidelines for prevention and treatment of osteoporosis. Utilization of metabolic markers of bone in daily osteoporosis practice].
The evaluation of metabolic state is thought to be useful for the risk evaluation of fractures and early evaluation of treatment effects. The evaluation may also be useful to maintain adherence to osteoporosis treatment, especially in patients without symptoms. The most markers are reimbursed, although number and timing of the evaluation are limited. The guidelines are published, and it is common practice to evaluate metabolic conditions of osteoporotic patients. They are especially useful to decision making for treatment not only in patients but also in physicians. The follow-up evaluation of the markers is useful in patients treated with bisphosphonate, raloxifene and/or vitamin K2 to maintain adherence.
Miki
Takami
T
Osaka City University Medical School, Postgraduate School of Medicine, Geriatric Medicine.
Masaki
Hideki
H
D015415:Biomarkers / Q000032:analysis; D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000008:administration & dosage; D004164:Diphosphonates / Q000008:administration & dosage; D005598:Fractures, Spontaneous / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D010024:Osteoporosis / Q000150:complications / Q000175:diagnosis* / Q000517:prevention & control / Q000628:therapy*; D020849:Raloxifene Hydrochloride / Q000008:administration & dosage; D018570:Risk Assessment; D024482:Vitamin K 2 / Q000008:administration & dosage
D015415:Biomarkers; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D024482:Vitamin K 2; D020849:Raloxifene Hydrochloride